Mereo BioPharma Group plc (FRA:MAH0)
Germany · Delayed Price · Currency is EUR 0.3570
-0.0090 (-2.46%)
At close: Jan 30, 2026
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of €58.93 million as of January 30, 2026. Its market cap has decreased by -87.08% in one year.
Market Cap
58.93M
Enterprise Value
18.28M
Revenue
426.15K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.36
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from 111.54M to 58.93M, a decrease of -47.16%. That is a compound annual growth rate of -8.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 58.93M | 4.35% |
| Dec 31, 2025 | 56.48M | -89.21% |
| Dec 31, 2024 | 523.66M | 78.98% |
| Dec 29, 2023 | 292.57M | 257.14% |
| Dec 30, 2022 | 81.92M | -46.41% |
| Dec 31, 2021 | 152.86M | -22.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoTec TSS AG | 69.38M |
| audius SE | 67.91M |
| learnd SE | 60.39M |
| WASGAU Produktions & Handels AG | 59.40M |
| Nordwest Handel AG | 58.97M |
| capsensixx AG | 58.59M |
| Schwälbchen Molkerei Jakob Berz AG | 58.16M |
| Infas Holding AG | 57.60M |